Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.
Marks, Michael;
Gwyn, Sarah;
Toloka, Hilary;
Kositz, Christian;
Asugeni, James;
Asugeni, Rowena;
Diau, Jason;
Kaldor, John M;
Romani, Lucia;
Redman-MacLaren, Michelle;
+5 more...MacLaren, David;
Solomon, Anthony W;
Mabey, David CW;
Steer, Andrew C;
Martin, Diana;
(2020)
Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 (12).
pp. 3226-3228.
ISSN 1058-4838
DOI: https://doi.org/10.1093/cid/ciaa584
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
The prevalence of antibodies to Strongyloides stercoralis was measured in 0-12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P = .019), demonstrating collateral benefits of ivermectin MDA in this setting.